ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 229

$692K Total Retail Price of All Prescriptions

Rank: 24 out of 229

438 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,052 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 609 536 1 1
LISINOPRIL 580 536 2 2
SIMVASTATIN 403 349 3 3
OMEPRAZOLE 383 330 4 4
METFORMIN HCL 354 275 5 6
AMLODIPINE BESYLATE 335 302 6 5
FUROSEMIDE 295 248 7 8
POTASSIUM CHLORIDE 224 201 8 18
HYDROCODONE-ACETAMINOPHEN 222 191 S3 9 7
METOPROLOL SUCCINATE 218 173 10 16
LOSARTAN POTASSIUM 198 185 11 12
METOPROLOL TARTRATE 167 144 12 13
HYDROCHLOROTHIAZIDE 152 140 13 9
ATORVASTATIN CALCIUM 144 114 14 15
WARFARIN SODIUM 142 119 15 17
GABAPENTIN 142 114 15 10
DONEPEZIL HCL 133 128 17 29
GLIMEPIRIDE 132 109 18 63
LOVASTATIN 128 128 19 11
ATENOLOL 127 108 20 19
TAMSULOSIN HCL 125 117 21 24
ALENDRONATE SODIUM 120 118 22 14
CARVEDILOL 104 101 23 31
CLOPIDOGREL 103 90 24 44
ALLOPURINOL 94 87 25 27
NEXIUM 94 77 25 48
SPIRONOLACTONE 91 75 27 56
TRAMADOL HCL 89 70 28 26
NAMENDA 88 88 29 39
TRAZODONE HCL 88 73 29 34
SPIRIVA 84 84 31 76
ZOLPIDEM TARTRATE 83 70 32 20
CELEBREX 82 66 33 71
SERTRALINE HCL 81 71 34 22
FLUOXETINE HCL 80 67 35 41
PLAVIX 80 67 35 72
ISOSORBIDE MONONITRATE ER 79 71 37 99
SYNTHROID 77 77 38 46
CRESTOR 77 77 38 30
DIOVAN HCT 76 74 40 114
FLUTICASONE PROPIONATE 70 56 41 23
ACTONEL 70 63 41 156
GLIPIZIDE 70 46 41 36
PRAVASTATIN SODIUM 69 56 44 25
DIOVAN 68 51 45 42
CLONIDINE 67 61 46 179
ADVAIR DISKUS 65 60 47 47
DIGOXIN 64 55 48 92
PROAIR HFA 63 50 49 38
KLOR-CON M10 63 60 49 161
CITALOPRAM HBR 63 58 49 21
GEMFIBROZIL 61 47 52 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 54 52 28
OXYBUTYNIN CHLORIDE 58 56 54 97
OXYCODONE-ACETAMINOPHEN 57 43 S2 55 43
LYRICA 55 39 56 100
AMITRIPTYLINE HCL 54 53 R 57 66
SINGULAIR 54 43 57 119
MIRTAZAPINE 51 51 59 52
PANTOPRAZOLE SODIUM 51 40 59 33
AZITHROMYCIN 50 43 61 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.